Related by context. All words. (Click for frequent words.) 77 Allovectin 7 R 75 Allovectin 7 73 YONDELIS 73 neratinib 73 ixabepilone 73 MAGE A3 ASCI 72 Panzem R NCD 72 oral ridaforolimus 71 forodesine 71 Amrubicin 70 paclitaxel Taxol ® 70 Xanafide 70 #D#C# 70 Velcade bortezomib 70 R sorafenib tablets 70 HuMax CD4 70 Phase #b/#a clinical 70 sorafenib tablets 70 docetaxel Taxotere ® 69 alvespimycin 69 Bezielle 69 docetaxel Taxotere R 69 EFAPROXYN 69 Aflibercept 69 vismodegib 69 Octreolin 69 dirucotide MBP# 69 OncoVEX GM CSF 69 HCD# [002] 69 amrubicin 69 Advexin 69 pain palliation 69 Canvaxin TM 69 Genasense ® 69 axitinib 69 samalizumab 69 Tarceva TM 69 EOquin TM 69 ganetespib 68 LEUKINE 68 UPLYSO 68 acyclovir Lauriad R 68 oral deforolimus 68 bendamustine 68 Tesmilifene 68 OPAXIO 68 sorafenib Nexavar 68 TEMODAL 68 paclitaxel Taxol R 68 EndoTAGTM 1 68 Daclizumab 68 receptor tyrosine kinase inhibitor 68 Vicinium TM 68 Dacogen injection 68 Asentar 68 LBH# 68 low dose cytarabine 68 evaluating tivozanib 68 Dacogen decitabine 68 successfully commercialize Iluvien 68 RhuDex ® 68 PD LID 68 elotuzumab 68 Certican 68 Pemetrexed 68 Onrigin 68 HGS# 68 sunitinib malate 68 tolevamer 68 dacarbazine 68 erlotinib Tarceva ® 68 refractory CLL 68 adecatumumab 68 gemcitabine carboplatin 68 SUTENT ® 68 ongoing Phase 1b 68 trabectedin 68 EndoTAG TM -1 68 ACTEMRA TM 68 deforolimus 67 refractory APL 67 phase IIb trial 67 oxymorphone ER 67 relapsed MM 67 Seliciclib 67 mertansine 67 Sebivo 67 PHX# 67 phase IIb clinical 67 enzastaurin 67 Zybrestat 67 aflibercept 67 Targretin capsules 67 HuLuc# 67 MGd 67 galiximab 67 generation purine nucleoside 67 bortezomib Velcade 67 pegylated interferon alfa 2a 67 Tamibarotene 67 DCVax ® Brain 67 Viramidine 67 KNS # 67 telaprevir VX 67 REOLYSIN ® 67 ThermoDox R 67 CINTREDEKIN BESUDOTOX 67 refractory chronic lymphocytic 67 paclitaxel poliglumex 67 ELACYT 67 lumiliximab 67 Phase Ib study 67 lintuzumab 67 DEB# 67 Taxotere ® 67 relapsed SCLC 67 eniluracil 67 Cloretazine 67 trastuzumab DM1 67 regorafenib 67 PSMA ADC 67 Syncria 67 TroVax ® 67 Phase IIb clinical trials 67 OvaRex ® MAb 67 BRIM2 67 UVIDEM 67 Peginterferon alfa 2b 67 HGS ETR1 67 Insegia 67 eribulin mesylate 67 humanised monoclonal antibody 67 Pazopanib 67 Neuradiab 67 Aplidin 67 Traficet EN 67 BEXXAR 67 Fodosine 67 novel VDA molecule 67 Nexavar ® 67 Proxinium TM 67 GW# [003] 67 Canvaxin 67 Arranon 67 radiolabeled TM# 67 orBec 67 systemic ALCL 67 TRISENOX 67 SUCCEED trial 67 PROSTVAC ® 67 PRECISE Trial 67 volociximab 67 CHOP chemotherapy 67 proteasome inhibitor 67 Omacetaxine 66 Phase Ib II 66 TORISEL 66 IL# PE#QQR 66 IMA# 66 Phase IIIb clinical 66 velafermin 66 TTF Therapy 66 Glufosfamide 66 calcineurin inhibitors 66 HER2 positive metastatic breast 66 mapatumumab 66 BrachySil TM 66 intravesical infusion therapy 66 AEG# 66 Eliquis 66 docetaxel Taxotere 66 viral kinetics 66 docetaxel chemotherapy 66 Intravenous CP 66 Golimumab 66 visilizumab 66 Hycamtin 66 PROCHYMAL 66 INCB# [001] 66 carboplatin paclitaxel 66 biologic therapy 66 recurrent NSCLC 66 Afatinib 66 pomalidomide 66 marketed pegylated interferons 66 decitabine 66 cilengitide 66 gemcitabine cisplatin 66 Peg IFN 66 Diamyd ® 66 anti angiogenic agents 66 pertuzumab 66 rALLy trial 66 Kamada AAT 66 Panzem R 66 PrevOnco 66 Nexavar sorafenib 66 Onconase 66 lintuzumab SGN 66 CIMZIA TM 66 Temsirolimus 66 demonstrated antitumor activity 66 HuMax EGFr 66 adult chronic ITP 66 tremelimumab 66 Nicole Onetto MD 66 BAY #-# 66 OvaRex MAb 66 TELINTRA 66 estramustine 66 PEG interferon 66 PXD# 66 romidepsin 66 Virulizin ® 66 Clolar ® 66 teriflunomide 66 ZOLINZA 66 valopicitabine 66 lenalidomide Revlimid R 66 MGN# 66 taxane chemotherapy 66 otelixizumab 66 Revimmune 66 vidofludimus 66 Panzem 66 tanespimycin 66 Vidaza azacitidine 66 synthetic retinoid 66 OncoVEX 66 relapsed refractory multiple myeloma 66 dalbavancin 66 gemcitabine chemotherapy 66 PEG SN# 66 Specifid 66 pegylated interferon alpha 66 rALLy clinical trial 66 thalidomide Thalomid 66 Bayer HealthCare Onyx Pharmaceuticals 66 nonsmall cell lung cancer 66 huC# DM4 66 pediatric acute lymphoblastic 66 JAK inhibitor 66 voclosporin 66 Campath alemtuzumab 66 SAR# [004] 66 immunosuppressive regimens 66 goserelin 66 huN# DM1 66 Gemzar ® 66 IMiDs 66 anti angiogenic therapy 66 Fludara 66 riociguat 66 Civacir 66 PrevOnco ™ 66 metastatic RCC 66 fluoropyrimidine 66 stage IIIB IV 66 PEG Interferon lambda 66 RAPTIVA 66 Mepact 66 talactoferrin 66 standard chemotherapy regimens 66 CYT# potent vascular disrupting 66 tramiprosate Alzhemed TM 66 HCV SPRINT 66 bevacizumab Avastin ® 66 Vandetanib 66 pegylated interferons 66 CAELYX 66 APTIVUS 66 Phase #/#a trial 66 phase Ib 66 sapacitabine CYC# 66 GAMMAGARD 66 trastuzumab Herceptin R 66 phase IIa clinical 65 trastuzumab DM1 T DM1 65 GVAX ® 65 CR# vcMMAE 65 G#DT 65 HGS ETR2 65 Vitaxin 65 Raptiva ® 65 MyVax R 65 Solazed 65 BCG refractory 65 OHR/AVR# 65 motesanib 65 custirsen 65 registrational trial 65 TYZEKA 65 Urocidin 65 ROTATEQ 65 TOCOSOL Paclitaxel 65 nab paclitaxel 65 interferon gamma 1b 65 multicenter Phase II 65 DCVax R 65 antiangiogenic therapy 65 ponatinib 65 ospemifene 65 CTAP# Capsules 65 PEGylated interferon 65 zalutumumab 65 FASLODEX 65 oral antiviral 65 Herceptin trastuzumab 65 thymalfasin 65 pemetrexed Alimta 65 refractory Hodgkin lymphoma 65 Genz # 65 OvaRex R 65 Azedra 65 Chemophase 65 Xeloda ® 65 HepaGam B TM 65 initiate Phase 1b 65 immunomodulatory therapy 65 PI3K/Akt pathway inhibitor 65 thetreatment 65 BrachySil 65 Votrient 65 tenofovir emtricitabine 65 oral prodrug 65 peg interferon 65 Torisel 65 GRN# 65 Urocidin TM 65 sunitinib Sutent 65 RhuDex TM 65 concurrent chemoradiation 65 Ixempra 65 AzaSite Plus 65 radiation sensitizer 65 ASONEP 65 evaluating REVLIMID 65 pralatrexate 65 CoFactor 65 Cloretazine ® 65 neoadjuvant therapy 65 Tavocept 65 Campath ® 65 temsirolimus 65 metastatic GIST 65 Ceflatonin 65 confirmatory clinical 65 SinuNase 65 GLP toxicology studies 65 cytokine refractory 65 MEK inhibitors 65 Neulasta ® 65 Centralized Procedure 65 Irinotecan 65 refractory multiple myeloma 65 Pegasys plus Copegus 65 GALNS 65 indibulin 65 Reverset 65 Cethrin 65 maribavir 65 Tarceva erlotinib 65 CDP# 65 Phase 1b clinical trials 65 TBC# 65 liposomal formulation 65 R vitespen 65 CLARITY study 65 MyVax 65 Dr. McHutchison 65 chemotherapeutic regimens 65 Carfilzomib 65 rindopepimut 65 chemoradiation therapy 65 alfa 2a 65 vemurafenib 65 Aurora kinase inhibitor 65 Vectibix panitumumab 65 liposomal doxorubicin 65 Fludara ® 65 AQ4N 65 EOquin 65 KRAS status 65 DermaVir Patch 65 HCV protease inhibitors 65 Sudhir Agrawal D.Phil 65 PRT# 65 ruxolitinib 65 JAK2 inhibitor 65 DU #b 65 cediranib 65 Thalomid ® 65 Tekamlo 65 eltrombopag 65 anti EGFR antibody 65 Imprime PGG 65 ToGA 65 nitazoxanide 65 BCIRG 65 ZACTIMA 65 ADVEXIN therapy 65 NP2 Enkephalin 65 preclinically 65 pradefovir 65 IIa trial 65 Copegus ribavirin 65 dosage regimens 65 Certolizumab pegol 65 dasatinib Sprycel ® 65 Vernakalant 65 Clevudine 65 LymphoStat B belimumab 65 Gliadel Wafer 65 reduce serum phosphate 65 Pegasys peginterferon alfa 2a 65 Doxil ® 65 Quinamed 65 PROSTVAC TM 65 JAK inhibitors 65 REGN# 65 LymphoStat B TM 65 Archexin 65 IMC A# 65 Fibrillex TM 65 relapsed multiple myeloma 65 TYGACIL 65 R# #mg BID 65 vinflunine 65 APTIVUS ritonavir 65 PANVAC VF 65 Alocrest 65 ACZ# 64 recurrent metastatic 64 Plicera 64 Proleukin 64 ISTODAX 64 Anthim 64 Hedgehog antagonist 64 anthracyclines taxanes 64 recurrent GBM 64 phase III isavuconazole 64 urocortin 2 64 THALOMID 64 mycophenolate mofetil 64 TYKERB 64 PDE4 inhibitor 64 HuMax TAC 64 Zevalin consolidation 64 Trastuzumab DM1 64 MAXY alpha 64 boosted protease inhibitor 64 IMiDs ® compound 64 Egrifta 64 RSD# oral 64 Alemtuzumab 64 TORISEL TM 64 Shigamabs ® 64 Proellex TM 64 evaluating satraplatin 64 recurrent metastatic ovarian cancer 64 placebo intravenously 64 iniparib 64 recurrent glioblastoma 64 dose escalation phase 64 Trovax 64 R roscovitine 64 Bendamustine 64 Sandostatin LAR Depot 64 lenalidomide dexamethasone 64 Evoltra ® 64 Silodosin 64 bevirimat Study 64 IV acetaminophen 64 KRN# 64 maximally tolerated dose 64 Taxotere R 64 XL# XL# XL# XL# 64 erlotinib Tarceva 64 previously untreated follicular 64 RhuDex R 64 MGCD# [001] 64 MOZOBIL 64 gefitinib Iressa 64 Ceplene/IL-2 64 Zemplar Capsules 64 metastatic CRC 64 StemEx R 64 Amigal 64 postoperative chemotherapy 64 Platinol ® cisplatin 64 XYOTAX TM 64 Degarelix 64 antibody MAb 64 AMEVIVE 64 reslizumab 64 tesmilifene 64 DCVax ® 64 metastatic bladder 64 active comparator 64 registrational 64 pegfilgrastim 64 depsipeptide 64 Azixa 64 drug ISA# 64 BCR ABL inhibitor 64 de novo kidney transplant 64 alkylating agent 64 subcutaneous PRO 64 panitumumab 64 IMiDs ® 64 Annamycin 64 taxane therapy 64 Dasatinib 64 histone deacetylase HDAC inhibitor 64 TELCYTA 64 lasofoxifene 64 omega interferon 64 TACI Ig 64 YONDELIS R 64 relapsed ovarian cancer 64 vandetanib 64 Talabostat 64 Advagraf 64 TransVax tm 64 Trofex 64 GSK# [001] 64 oral picoplatin 64 oral talactoferrin 64 hypoxia activated prodrug 64 Telintra 64 vinorelbine 64 bevacizumab Avastin 64 Phase #/#a 64 RGB # 64 Perifosine 64 Cimzia TM 64 glufosfamide 64 CELVAPAN H#N# 64 Teysuno 64 efalizumab 64 Taxotere chemotherapy 64 SIR Spheres 64 Phase IIb trials 64 Hepatocellular Carcinoma HCC 64 Aptivus ® 64 BRAF V# mutation 64 BCR ABL inhibitors 64 Zavesca R 64 PEG PAL 64 cisplatin gemcitabine 64 sorafenib Nexavar ® 64 ularitide 64 somatostatin analogues 64 Lenocta 64 Phase Ib IIa 64 elvucitabine 64 recurrent glioblastoma multiforme 64 ulimorelin 64 Cytoxan 64 vosaroxin 64 Apaziquone 64 Abiraterone acetate 64 SOM# 64 Clolar 64 elacytarabine 64 gastrointestinal stromal tumors 64 IMGN# 64 FTY# 64 oxaliplatin Eloxatin 64 refractory AML 64 Simulect 64 GRNVAC1 64 metastatic HRPC 64 budesonide MMX Phase III 64 dacetuzumab 64 AZILECT ® 64 daptomycin 64 BR.# 64 ZADAXIN ® 64 MEK Inhibitor 64 class mGluR5 inhibitor 64 gadobutrol 64 induced macular edema 64 pharmacodynamic properties 64 unresectable stage 64 CIMZIA ™ 64 clevidipine 64 Oral NKTR 64 EndoTAG 64 TransVax ™ 64 TG# [003] 64 tecarfarin 64 Gleevec Glivec 64 oral rivaroxaban 64 ANYARA 64 Aryplase 64 VEGF Trap 64 lymphoid malignancies 64 Xelox 64 pafuramidine 64 bortezomib Velcade R 64 pegylated alpha interferon 64 sapacitabine 64 celgosivir 64 protease inhibitor PI 64 novel oral anticoagulant 64 Arimoclomol 64 PROMACTA 64 Amplimexon 64 Cariprazine 64 Sapacitabine 64 SCIg 64 bardoxolone 64 TRISENOX ® 64 Taxotere docetaxel 64 Exelixis compounds 64 Zerenex 64 Mylotarg 64 oral clodronate 64 oral antidiabetic 64 HepeX B 64 personalized immunotherapy 64 PREZISTA r 64 trastuzumab Herceptin ® 64 DexaSite 64 dirucotide 64 multiple myeloma MM 64 danoprevir 64 ZK EPO 64 MKC# MT 64 HGS ETR1 mapatumumab 63 Hsp# Inhibitor 63 L BLP# 63 BLA filing 63 registrational studies 63 Q#IR 63 ORENCIA R 63 microtubule inhibitor 63 eprotirome 63 AZILECT R 63 gemcitabine Gemzar ® 63 cardio renal 63 capecitabine Xeloda 63 Evoltra 63 atacicept 63 KRAS mutations occur 63 investigational therapies 63 neoadjuvant treatment 63 GVAX 63 standard chemotherapy regimen 63 gemcitabine Gemzar 63 clofarabine 63 Arikace 63 blinded randomized placebo controlled 63 BRIM3 63 tubulin inhibitor 63 stage IIIB 63 Tarvacin 63 XL# anticancer compounds 63 Pertuzumab 63 Glivec imatinib 63 randomized Phase 2b 63 SNT MC# 63 Teriflunomide 63 eritoran 63 REBETOL combination therapy 63 Vaxfectin TM 63 chemotherapeutic regimen 63 DORIBAX 63 midstage clinical 63 Æterna Zentaris 63 MORAb 63 IRESSA 63 Gleevec imatinib mesylate 63 squamous non 63 anticancer therapy 63 dacarbazine chemotherapy 63 DOXIL 63 GnRH antagonist 63 Telatinib 63 EndoTAG TM 63 tezampanel 63 dose cohorts 63 SinuNase TM 63 Ocrelizumab 63 budesonide foam 63 ocrelizumab 63 dasatinib Sprycel 63 sunitinib 63 metastatic colorectal 63 hepatitis C HCV 63 SNT-MC#/idebenone 63 INC# 63 weekly subcutaneous injections 63 phase IIa 63 valopicitabine NM# 63 Icatibant 63 TransVax 63 TransVax TM 63 ancrod 63 alvimopan 63 CA9 SCAN 63 chemotherapy docetaxel 63 BioNumerik 63 Darinaparsin 63 TAFA# 63 trivalent influenza vaccine 63 biologic DMARD 63 LHRH antagonist 63 VELCADE melphalan 63 Pentacel vaccine 63 tivozanib 63 TNF alpha inhibitor 63 pegylated liposomal doxorubicin 63 XYOTAX 63 chemoradiotherapy 63 TREANDA 63 Exforge HCT 63 novel emulsion formulation 63 Neupogen ® 63 farletuzumab 63 dopamine partial agonist 63 anti CD# antibodies 63 Xerecept 63 DCVax Brain 63 sargramostim 63 MVax 63 pharmacokinetic PK study 63 IgG1 monoclonal antibody 63 MoxDuo IR 63 methylnaltrexone 63 palliative radiotherapy 63 phase IIb study 63 targeted radiotherapeutic 63 apaziquone 63 xanthine oxidase inhibitor 63 Pfizer Sutent 63 potentially hepatotoxic 63 CEQ# 63 Voreloxin 63 Temodar ® 63 nonclinical studies 63 TNF inhibitor 63 dosing cohort 63 non squamous NSCLC 63 Vaxfectin 63 recombinant interferon 63 K ras mutations 63 Virulizin R 63 Surgical resection 63 Pegintron 63 rituximab Rituxan 63 sorafenib Nexavar R 63 Pimavanserin 63 CCX# 63 virus HCV protease inhibitor 63 injectable formulations 63 cannabinor 63 Onrigin TM 63 infusional 5-FU/LV 63 faropenem 63 Perforomist ™ Inhalation Solution 63 pancreatic neuroendocrine tumors 63 OMP #M# 63 LibiGel Phase III 63 LUMINATE 63 peg IFN 63 Genentech Herceptin 63 DCVax R Brain 63 tocilizumab 63 rilonacept 63 orally dosed 63 resminostat 63 therapeutic regimens 63 oral salmon calcitonin 63 Telavancin 63 AeroLEF 63 CCR5 receptor antagonist 63 histologies 63 AIMM trial 63 alefacept 63 nucleotide analogue 63 via intradermal injections 63 advanced hepatocellular carcinoma 63 eprodisate Fibrillex TM 63 Phase 2b kidney transplant 63 Phase Ib 63 GEM OS2 63 Revlimid lenalidomide 63 QuadraSphere 63 GVAX Pancreas Vaccine 63 AEGR 63 including eniluracil ADH 63 IMC #B 63 Toctino ® alitretinoin 63 HEPLISAV 63 ONCASPAR 63 carcinoma HCC 63 StemEx 63 INTERCEPT platelets 63 chronic ITP patients 63 transgenically produced product 63 Selective Electrochemical Tumor Ablation 63 unresectable 63 metastatic renal cell carcinoma 63 anthracycline taxane 63 Bortezomib 63 Sym# 63 CONBRIZA 63 Personalized Immunotherapy 63 azacitidine 63 orally administered inhibitor 63 Bicifadine 63 obatoclax 63 NEUPOGEN 63 Zolinza 63 HQK 63 oral FTY# 63 Prednisporin 63 interferon alfa 2b 63 cytotoxic chemotherapy 63 dexanabinol 63 OMS# 63 phase IIb III 63 ELND# 63 μg dose 63 mRCC 63 HFA MDI 63 EGFR expressing mCRC 63 Teplizumab 63 COPEGUS 63 BRAF inhibitor 63 midstage trials 63 milatuzumab 63 metastatic neuroendocrine tumors 63 Phase IIa clinical trials 63 FOR FURTHER INFORMATION ABOUT 63 mifamurtide 63 radiation chemoradiation 63 Lenalidomide 63 oral methylnaltrexone 63 PARP inhibitor 63 Exherin TM 63 taxane 63 ZYBRESTAT fosbretabulin 63 MAA submission 63 GLPG# 63 tezampanel NGX# 63 MKC# PP 63 vorinostat 63 MabCampath 63 Ixabepilone 63 chemoradiation 63 dose cohort 63 Increlex R 63 small molecule Hedgehog 63 IRX 2 63 FOLOTYN ® 63 TNF antagonist 63 taxane refractory 63 indolent NHL 63 Yondelis ® 63 beta 1a 63 ADP receptor antagonist 63 Clofarabine 63 evaluating Xcytrin 63 Ganite ® 63 Tolamba 63 Alimta pemetrexed 63 relapsing remitting MS RRMS 63 HuMax CD# 63 subcutaneous formulation 63 GED aPC 63 NeuroFlo 63 sipuleucel T 63 Altera Nebulizer System 63 treatment naive genotype 63 MNTX 63 nilotinib Tasigna ® 63 phase IIb 63 ImmunoVEX HSV2 63 Maribavir 63 mTOR inhibition 63 Phase IIa trials 63 anthracycline containing 63 CMV vaccine 63 metaglidasen 63 nucleoside analog 63 Romiplostim 63 Immunotherapeutic 63 torezolid phosphate 63 PNP inhibitor 63 zanolimumab 63 randomized controlled Phase 63 Behcet uveitis 63 brivanib 63 Nexavar tablets 63 platinum refractory 63 ENMD # 63 glatiramer 63 PDX pralatrexate 63 panitumumab Vectibix 63 NSABP B 63 treatment naïve genotype 63 NEUGENE antisense 63 fusion enhancers 63 NovoTTF 63 placebo controlled clinical 63 fallopian tube cancers 63 GVAX R 63 recurrent malignant glioma 63 non nucleoside HCV 63 Nanobody 63 Ketotransdel 62 certolizumab 62 Aggrastat ® tirofiban hydrochloride 62 Arsenic trioxide 62 Tectin TM 62 MyVax personalized immunotherapy 62 Doxil 62 ReN# 62 Removab 62 investigational monoclonal antibody 62 calcineurin inhibitor 62 irinotecan chemotherapy 62 abiraterone acetate 62 Troxatyl 62 ozarelix 62 JANUVIA 62 MYLOTARG 62 Tanespimycin 62 ongoing Phase IIIb 62 Phase IIIb study 62 INCB# [002] 62 intra arterial chemotherapy 62 incyclinide 62 PROSTVAC VF 62 OncoGel 62 antihypertensive agents 62 XmAb# 62 Oxaliplatin 62 unresectable liver cancer 62 Panzem NCD 62 dose dose escalation 62 systemically administered 62 TheraCIM 62 interferon alfa 62 peginterferon alfa 2b 62 Novartis MenB vaccine 62 Onco TCS 62 ribavirin RBV 62 Phase IIb III 62 OMAPRO 62 saline placebo 62 Ophena TM 62 DAVANAT 62 EGS# 62 5 fluorouracil leucovorin 62 LUVENIQ 62 Diamyd R 62 immunosuppressive regimen 62 briakinumab 62 double blinded placebo 62 NEUMUNE 62 MVax R 62 NV1FGF 62 Omnitarg 62 Elitek 62 ADVEXIN 62 Lorianne Masuoka MD 62 Jevtana 62 Delcath System 62 INSPIRE Trial Phase III 62 azilsartan medoxomil 62 Anturol TM 62 uric acid lowering 62 TOLAMBA 62 TAXOTERE R 62 radiochemotherapy 62 vinca alkaloid 62 Gleevec resistant 62 brostallicin 62 posaconazole 62 CBLC# 62 ProMune 62 inhaled AAT 62 brentuximab vedotin SGN 62 brivaracetam 62 Panitumumab 62 COMFORT II 62 TPI ASM8 62 REMICADE ® 62 #mg dose [002] 62 SCCHN 62 CVac 62 TroVax 62 RANK Ligand inhibitor 62 SPRYCEL ® 62 ARIKACE ™